검색결과 : 7건
| No. | Article |
|---|---|
| 1 |
Mass spectrometry for quality control of bispecific antibodies after SDS-PAGE in-gel digestion Horner S, Ghosh M, Kauer J, Spat P, Rammensee HG, Jung G, Pflugler M Biotechnology and Bioengineering, 118(8), 3069, 2021 |
| 2 |
Actively personalized vaccination trial for newly diagnosed glioblastoma (vol 565, pg 240, 2018) Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanovic S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Straten PT, Martinez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piro J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Lower M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Bruck A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rossler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W Nature, 566(7745), E13, 2019 |
| 3 |
Actively personalized vaccination trial for newly diagnosed glioblastoma Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanovic S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Straten PT, Martinez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piro J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Lower M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Bruck A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rossler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W Nature, 565(7738), 240, 2019 |
| 4 |
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Gubin MM, Zhang XL, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SSK, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJM, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD Nature, 515(7528), 577, 2014 |
| 5 |
CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity Jekle A, Obst R, Lang F, Rammensee HG, Gulbins E Biochemical and Biophysical Research Communications, 272(2), 395, 2000 |
| 6 |
Perfect use of imperfection Schild H, Rammensee HG Nature, 404(6779), 709, 2000 |
| 7 |
A Role for the Proteasome Regulator Pa28-Alpha in Antigen Presentation Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, Schild H, Rammensee HG, Koszinowski UH, Kloetzel PM Nature, 381(6578), 166, 1996 |